MicroRNA-508-3p Level in the Blood of Kidney Cancer Patients
##plugins.themes.bootstrap3.article.main##
Abstract
The aim of our study was to establish the expression of miR-508-3p in the blood of patients with KC and healthy subjects.
Levels of miR-508-3p were quantified in the blood samples of 67 patients with renal cell carcinoma and 64 controls using real-time PCR. The level of this microRNA appeared significantly lower in KC patients compared to controls.
The cut-off level of miR-508-3p in KC is 12.7 relative units.
Sensitivity of miR-508-3p level for KC in our study is 82,% and specificity – 89,6%.
In conclusion, miR-508-3p level in blood can be considered as a possible diagnostic marker of kidney cancer.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Банира О.Б. Рак нирки: пошук універсального маркера / О.Б. Банира, О.О. Строй, О.В. Шуляк // Укр. мед. часопис. – 2012. – No 2 (88). – С. 55–61.
Строй О.О. Цінність мікро-РНК 508-3р у діагностиці раку нирки / О.О. Строй, О.Б. Банира, В.Є. Досенко та співавт. // Укр. мед. часопис. – 2012. – No 6 (92). – С. 118–121.
Gu L. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis / L. Gu, H. Li, L. Chen et al. // Oncotarget. – 2015. – No 6 (32). – Р. 32545–60.
Li M. Biomarkers for Renal Cell Carcinoma. Kidney Cancer: Principles and Practice, Primo N. Lara Jr., Jonasch Eric (Eds.) / M. Li, W.K/ Rathmell. – Springer, 2012. – Р. 47–65.
Nofech-Mozes R. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma / R. Nofech-Mozes, H.W. Khella, A. Scorilas et al. // Cancer Med. – 2016. – 5 (4). – Р. 656–664.
Norman G.R. Biostatistics: The Bare Essentials, 3rd Edition / G.R. Norman, D.L. Streiner // PMKC-USA, 2008. – 393 p.
Rasti A. Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol / A. Rasti, M. Mehrazma, Z. Madjd et al. // BMJ Open. – 2016. – Jan 4, No 6 (1). – Р. E009667.
Redova M. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma / M. Redova, A. Poprach, J. Nekvindova et al. // J. Transl. Med. – 2012. – No 10 (1). – Р. 55.
Samaan S. miR-210 is a prognostic marker in clear cell renal cell carcinoma / S. Samaan, H.W. Khella, A. Girgis et al. // J Mol Diagn. – 2015, Mar. – No 17 (2). – Р. 136–144.
Tusong H. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma / H. Tusong, N. Maolakuerban, J. Guan et al. // Cancer Biomark. – 2017. – No 18(1). – Р. 79–85.
Wulfken L.M. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels / L.M. Wulfken, R. Moritz, C. Ohlmann et al. // PLoS One. – 2011. – No 6 (9). – Р. e25787.
Zar J.H. Biostatistical Analysis, 5th Edition / J.Y. Zar. – New York: Prentice Hall, 2009. – 960 p.
Zhai Q. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma / Q. Zhai, L. Zhou, C. Zhao et al. // Biochem. BioKCys. Res. Commun. – 2012. – No 419 (4). – Р. 621–626.